about
The danger theory: 20 years laterThe apoptotic signaling pathway activated by Toll-like receptor-2Preeclampsia: a view through the danger modelGene therapy for carcinoma of the breast: Genetic immunotherapyModelling vaccination schedules for a cancer immunoprevention vaccine.Metallothionein mediates leukocyte chemotaxis.The role of neutrophils in immune dysfunction during severe inflammationNeoplastic "Black Ops": cancer's subversive tactics in overcoming host defensesAdaptive learning by extremal dynamics and negative feedbackImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseAntigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivoThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityReversal of established traumatic brain injury-induced, anxiety-like behavior in rats after delayed, post-injury neuroimmune suppressionPlasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70.Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon responseAnti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production.Retinal laser burn disrupts immune privilege in the eye.Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.DNA and RNA-based vaccines: principles, progress and prospects.The promise of nucleic acid vaccines.Cancer gene therapy: hard lessons and new courses.Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy.Caspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival.Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.Leishmaniasis: current status of vaccine developmentFeeding dendritic cells with tumor antigens: self-service buffet or à la carte?DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide.Cancer gene therapy: developments to 2000.Type 1/Type 2 immunity in infectious diseases.The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.Gene therapy: development of immunostimulatory treatments for cancer.Lymphocyte modulation with FTY720 improves hemorrhagic shock survival in swineImmunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world.Essay 1: the Danger model in its historical context.The phosphatidylserine receptor: a crucial molecular switch?Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity.Regulatory T cells suppress antigen-driven CD4 T cell reactivity following injury.Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.Current concepts in contact dermatitis.T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.
P2860
Q21131221-95ACDFE5-F591-40E0-A742-1AB486CA9449Q22254416-C4260E4E-D2BE-4A80-BF26-A6613BB8239BQ24646220-952EA2D5-4F05-4998-809C-839FD57F2209Q24797848-0528A474-F85D-4B86-936C-B4DB75F43C1FQ24810987-5DFF148F-174D-4FA3-A15B-FFCCE4938FBBQ24815126-C539CD27-B718-4D1C-AE6F-C2E1C7C49F53Q26752629-A5CBC2A5-CFA9-4ED2-9F3C-FCB6F9262641Q27001081-9AB30DF8-2FFA-4E09-BA13-E8DC4DFEFE87Q27345315-2EB1DBE6-817A-4172-9AB5-286B77630C38Q28238379-8A7CF4E0-C13E-4267-971B-DDFB13F37169Q28364889-A65CAF60-0E8B-4AC5-9C5F-FE17FCEEE456Q28384138-7EF0BB81-2C84-462A-BEE4-96689627257FQ28396598-F5164B29-BF09-48CA-84B4-E63E453304CCQ31052590-2F6DF675-56C9-4CA7-B552-6C571185F847Q33278262-33107E64-506B-4CC4-B614-16C557DA3BCAQ33341449-CDC30863-91AB-4925-8235-18D2A66AD6FDQ33400237-23A32BB8-B26E-4656-9E33-7C214038EA4AQ33439759-145C1BAD-5588-4189-86D2-C9895BFBAB8CQ33783789-5051E1F0-FB85-44EE-85CE-DD88DD6A1229Q33837119-BF819B3D-97BE-4AE5-B19A-0E13F9F574BAQ33840974-04D73B65-C19C-4EF9-9355-D755D2EAC315Q33846007-FE1F1DF8-AD76-4D84-BB89-A98D4C0C04DBQ33869805-9623EE3E-5107-4707-8A53-751AA2A3B0F7Q33882512-4894EB13-7FEA-4027-BDA3-6E52CEC2EC2CQ33941719-2CFB7077-F56E-4884-8BFC-1BD1CAF5B58EQ33986125-02FC5A5D-4BB1-40C3-A636-AC7B13610171Q34006725-0A3F8721-1CF1-4443-98AD-B1BF6889731EQ34090963-5579C580-9B53-4C48-8D51-0EEC3B5CAF7AQ34105379-28A1BA27-E207-4E7A-B098-D549424B2D40Q34145128-AFAB3C14-51F4-41E7-A531-68CEA202DBB8Q34187915-F3E7FD34-04FA-4B74-8083-CDBB3665E2EBQ34256174-234702C3-E560-467C-AABA-F3C7794A5A80Q34294802-3CEA227C-DEA8-4283-80A9-6090CA40B0F1Q34299818-FD8D6D63-B62E-4F0E-9EB2-A563EC340DB4Q34325344-25F801C0-F258-4FF6-A21C-3BC42EBDC996Q34352839-67179D93-5C6F-4F5D-8E7E-36C52B819EFFQ34417516-BA30D9A1-F83C-4019-A29D-C707AEFF1979Q34433429-91EE1AE0-5920-43BB-8241-314C33465C55Q34434614-D05E2B9A-702B-4F11-9833-FDBC9586BF49Q34452013-81E71F88-0A08-454C-BE81-A86067DBE365
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1998
@uk
name
An innate sense of danger
@en
An innate sense of danger
@nl
type
label
An innate sense of danger
@en
An innate sense of danger
@nl
prefLabel
An innate sense of danger
@en
An innate sense of danger
@nl
P356
P1476
An innate sense of danger
@en
P2093
Polly Matzinger
P304
P356
10.1006/SMIM.1998.0143
P577
1998-10-01T00:00:00Z